Cooperative Groups Advised To Plan For Future Of Less Funding from NCI
In Brief: General Motors Cancer Research Foundation Prizewinners: Brock, Li, Fraumeni, Harlow
ODAC Recommends Ethyol, DaunoXome For FDA Approval
ORI Clears Los Angeles Physician Of Misconduct In NSABP Participation
Cancer Panel Urges Improved Funding For Basic Science
FDA, NIH Streamline Approvals For Gene Therapy Studies
Report Criticizes NIH Grant Review
NIH Policy On Diversity In Sponsored Meetings
Trending Stories
- Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - The Directors: Two Gulf Coast cancer center directors on why NCI designation matters—and why they want it
Lucio Miele and Raghu Kalluri: Science and technology have changed what an aspiring cancer center must accomplish - FDA advisory committee votes in favor of Galleri approval, but calls for removal of “early” detection claims
Clinical benefit will not be considered for approval, FDA says - Trump weighs—and abandons—an executive order that would give OMB veto power over NIH grants
- From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - The Galleri MCD vote: What FDA asked its advisors to ignore
